Cargando…

Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity

We increase our understanding of augmenting a cellular immune response, by using an HIV-1 protease-derived epitope (PR(75–84)), and variants thereof, coupled to the C-terminal, of the B subunit of cholera toxin (CTB). Fusion proteins were used for immunizations of HLA-A0201 transgenic C57BL/6 mice....

Descripción completa

Detalles Bibliográficos
Autores principales:	Boberg, Andreas, Stålnacke, Alexandra, Bråve, Andreas, Hinkula, Jorma, Wahren, Britta, Carlin, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890861/ https://www.ncbi.nlm.nih.gov/pubmed/27335661 http://dx.doi.org/10.5402/2012/170676

Ejemplares similares

Immunization with HIV protease peptides linked to syngeneic erythrocytes
por: Boberg, Andreas, et al.
Publicado: (2007)

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: Study of immunological memory and long-term toxicology
por: Bråve, Andreas, et al.
Publicado: (2007)

Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use
por: Wahren, Britta, et al.
Publicado: (2006)

Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice
por: Hinkula, Jorma, et al.
Publicado: (2019)

Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination
por: Falkeborn, Tina, et al.
Publicado: (2013)

Identification of Immunogenic Antigens of Naegleria fowleri Adjuvanted by Cholera Toxin
por: Rojas-Hernández, Saúl, et al.
Publicado: (2020)

Do circulating HIV vaccine plasmids contribute to immunogenicity in humans?
por: Wahren, B, et al.
Publicado: (2006)

Production of Pentameric Cholera Toxin B Subunit in Escherichia coli
por: Dakterzada, Farida, et al.
Publicado: (2012)

Cholera Toxin B: One Subunit with Many Pharmaceutical Applications
por: Baldauf, Keegan J., et al.
Publicado: (2015)

Preparation of cholera toxin subunit-B for use in vaccine preparation
Publicado: (1986)

Sensitive and rapid detection of cholera toxin subunit B using magnetic frequency mixing detection
por: Achtsnicht, Stefan, et al.
Publicado: (2019)

Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain
por: Shim, Byoung-Shik, et al.
Publicado: (2018)

A Protein-Based Pentavalent Inhibitor of the Cholera Toxin B-Subunit**
por: Branson, Thomas R, et al.
Publicado: (2014)

Cholera toxin B subunit induces local curvature on lipid bilayers
por: Pezeshkian, Weria, et al.
Publicado: (2017)

Anti-inflammatory effect of cholera toxin B subunit in experimental stroke
por: Zhang, Lei, et al.
Publicado: (2016)

Characterization and utility of two monoclonal antibodies to cholera toxin B subunit
por: Verjan Garcia, Noel, et al.
Publicado: (2023)

Immunization with Cholera Toxin B Subunit Induces High-Level Protection in the Suckling Mouse Model of Cholera
por: Price, Gregory A., et al.
Publicado: (2013)

A Conformational Shift in the Dissociated Cholera Toxin A1 Subunit Prevents Reassembly of the Cholera Holotoxin
por: Taylor, Michael, et al.
Publicado: (2015)

A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines
por: Hallengärd, David, et al.
Publicado: (2012)

A Therapeutic Chemical Chaperone Inhibits Cholera Intoxication and Unfolding/Translocation of the Cholera Toxin A1 Subunit
por: Taylor, Michael, et al.
Publicado: (2011)

Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa
por: Royal, Joshua M., et al.
Publicado: (2017)

Cholera Toxin Subunit B for Sensitive and Rapid Determination of Exosomes by Gel Filtration
por: Sapoń, Karolina, et al.
Publicado: (2020)

The Functions of Cholera Toxin Subunit B as a Modulator of Silica Nanoparticle Endocytosis
por: Susnik, Eva, et al.
Publicado: (2023)

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial
por: Nilsson, Charlotta, et al.
Publicado: (2015)

Repeated Oral Administration of a KDEL-Tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis despite a Robust Immunogenic Response
por: Royal, Joshua M., et al.
Publicado: (2019)

Mechanisms Underlying the Confined Diffusion of Cholera Toxin B-Subunit in Intact Cell Membranes
por: Day, Charles A., et al.
Publicado: (2012)

Cholera Toxin B Subunits Assemble into Pentamers - Proposition of a Fly-Casting Mechanism
por: Zrimi, Jihad, et al.
Publicado: (2010)

N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines?
por: Matoba, Nobuyuki
Publicado: (2015)

Cholera Toxin Subunit B as Adjuvant––An Accelerator in Protective Immunity and a Break in Autoimmunity
por: Stratmann, Thomas
Publicado: (2015)

Strong Inhibition of Cholera Toxin B Subunit by Affordable, Polymer-Based Multivalent Inhibitors
por: Haksar, Diksha, et al.
Publicado: (2019)

Cell type and receptor identity regulate cholera toxin subunit B (CTB) internalization
por: Sethi, Anirudh, et al.
Publicado: (2019)

Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev
por: Cardona, Maria E., et al.
Publicado: (2022)

Safety of the Recombinant Cholera Toxin B Subunit, Killed Whole-Cell (rBS-WC) Oral Cholera Vaccine in Pregnancy
por: Hashim, Ramadhan, et al.
Publicado: (2012)

Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant
por: Jia, Shuo, et al.
Publicado: (2020)

Immunogenicity of an S1D epitope from porcine epidemic diarrhea virus and cholera toxin B subunit fusion protein transiently expressed in infiltrated Nicotiana benthamiana leaves
por: Huy, Nguyen-Xuan, et al.
Publicado: (2016)

Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit
por: Lu, Wuguang, et al.
Publicado: (2015)

A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro
por: Chang, Chien-Hsing, et al.
Publicado: (2012)

Transmembrane signaling by the B subunit of cholera toxin: increased cytoplasmic free calcium in rat lymphocytes
Publicado: (1987)

Cholera Toxin B Subunit Shows Transneuronal Tracing after Injection in an Injured Sciatic Nerve
por: Lai, Bi-Qin, et al.
Publicado: (2015)

Recombinant toxin-coregulated pilus A (TcpA) as a candidate subunit cholera vaccine
por: Kiaie, Somayeh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_usr8lfos7fjpksbogm47q4cco3